Rifapentine Is Active in Vitro and in Vivo Against Toxoplasma Gondii.

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.40.6.1335
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

In Vivo Efficacy of Drugs Against Toxoplasma Gondii Combined With Immunomodulators

Japanese Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2016English

Spiroindolone That Inhibits PfATPase4 Is a Potent, Cidal Inhibitor of Toxoplasma Gondii Tachyzoites in Vitro and in Vivo

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2013English

Fusidic Acid Is an Effective Treatment Against Toxoplasma Gondii and Listeria Monocytogenes in Vitro, but Not in Mice

Parasitology Research
MedicineInfectious DiseasesParasitologyVeterinaryInsect Science
2013English

In Vitro Assays Elucidate Peculiar Kinetics of Clindamycin Action Against Toxoplasma Gondii

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1995English

In Vitro Effects ofIvermectin and Sulphadiazine on Toxoplasma Gondii

Balkan Medical Journal
Medicine
2013English

TgVTC2 Is Involved in Polyphosphate Accumulation in Toxoplasma Gondii

Molecular and Biochemical Parasitology
ParasitologyMolecular Biology
2011English

Autophagy Is a Cell Death Mechanism in Toxoplasma Gondii

Cellular Microbiology
VirologyImmunologyMicrobiology
2012English

Synthesis and Evaluation of Oryzalin Analogs Against Toxoplasma Gondii

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2010English

Comparative in Vivo Activities of Rifabutin and Rifapentine Against Mycobacterium Avium Complex.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy